Literature DB >> 20098446

Pituitary gland: predictors of acromegaly-associated mortality.

Anat Ben-Shlomo1.   

Abstract

Mortality rates are increased in acromegaly. previous studies have shown that growth hormone and insulin-like growth factor 1 levels, male gender,age, hypertension, delayed diagnosis and prior pituitary radiotherapy are independent predictors of increased mortality. A new study by Sherlock et al. now adds adrenal insufficiency and hydrocortisone replacement dose to the list of independent predictors of acromegaly-associated mortality.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20098446     DOI： 10.1038/nrendo.2009.267

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  9 in total

1.  Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

Authors:  J W Tomlinson; N Holden; R K Hills; K Wheatley; R N Clayton; A S Bates; M C Sheppard; P M Stewart
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

2.  Premature mortality in patients with Addison's disease: a population-based study.

Authors:  Ragnhildur Bergthorsdottir; Maria Leonsson-Zachrisson; Anders Odén; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

3.  A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.

Authors:  I M Holdaway; M J Bolland; G D Gamble
Journal:  Eur J Endocrinol       Date:  2008-06-04       Impact factor: 6.664

4.  A nationwide survey of mortality in acromegaly.

Authors:  Ritva Kauppinen-Mäkelin; Timo Sane; Antti Reunanen; Matti J Välimäki; Leo Niskanen; Helene Markkanen; Eliisa Löyttyniemi; Tapani Ebeling; Pia Jaatinen; Hanna Laine; Pirjo Nuutila; Pasi Salmela; Jorma Salmi; Ulf-Håkan Stenman; Jorma Viikari; Erkki Voutilainen
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

5.  Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.

Authors:  J Ayuk; R N Clayton; G Holder; M C Sheppard; P M Stewart; A S Bates
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

6.  AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects.

Authors:  Marie Bex; Roger Abs; Guy T'Sjoen; Jean Mockel; Brigitte Velkeniers; Katja Muermans; Dominique Maiter
Journal:  Eur J Endocrinol       Date:  2007-10       Impact factor: 6.664

7.  Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).

Authors:  Antonio Mestron; Susan M Webb; Ricardo Astorga; Pedro Benito; Miguel Catala; Sonia Gaztambide; Jose-Manuel Gomez; Irene Halperin; Tomas Lucas-Morante; Basilio Moreno; Gabriel Obiols; Pedro de Pablos; Concha Paramo; Antonio Pico; Elena Torres; Cesar Varela; Jose-Antonio Vazquez; Juana Zamora; Merce Albareda; Montserrat Gilabert
Journal:  Eur J Endocrinol       Date:  2004-10       Impact factor: 6.664

8.  ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.

Authors:  M Sherlock; R C Reulen; A Aragon Alonso; J Ayuk; R N Clayton; M C Sheppard; M M Hawkins; A S Bates; P M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2009-10-06       Impact factor: 5.958

9.  Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.

Authors:  Sophie Bensing; Lena Brandt; Farnoush Tabaroj; Olof Sjöberg; Bo Nilsson; Anders Ekbom; Paul Blomqvist; Olle Kämpe
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-22       Impact factor: 3.478
  9 in total
  3 in total

Review 1.  The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.

Authors:  Saptarshi Bhattacharya; Sanjay Kalra; Deep Dutta; Deepak Khandelwal; Rajiv Singla
Journal:  Eur Endocrinol       Date:  2019-10-18

2.  Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study.

Authors:  Chris Yedinak; Nadia Hameed; Marika Gassner; Jessica Brzana; Shirley McCartney; Maria Fleseriu
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

3.  Long-term safety of gamma knife radiosurgery (SRS) for acromegaly.

Authors:  Hugh P Sims-Williams; Kaveesha Rajapaksa; John Yianni; Lee Walton; Saurabh Sinha; Matthias Radatz; Esther Herbert; Mike Bradburn; John Newell-Price
Journal:  Pituitary       Date:  2021-05-26       Impact factor: 4.107
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.